Search Results 551-560 of 14768 for anti-TNF drugs

1. Fludarabine (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Nuclear Medicine Therapy - Clinical trials

   The purpose of this study is to compare capecitabine and temozolomide to lutetium Lu 177 dotatate for the treatment of pancreatic neuroendocrine tumors that ...

3. Factor Ix (Intravenous Route, Injection Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Alphanine SD; Alprolix; Bebulin; Bebulin VH ...

4. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

   Unstable biological therapy (e.g., TNF-α (anti-tumor necrosis factor), natalizumab, etc.), including significant changes in doses or switch of drug within 6 ...

5. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

   corticosteroids, immunomodulators (eg, AZA, 6-mercaptopurine, methotrexate), and/or TNF-α antagonist therapy (e.g., infliximab, adalimumab). This includes ...

6. Paclitaxel (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

7. To Beat 1 of the Biggest Killers, Scientists Think Small - Mayo Clinic News Network

   ... anti-cancer drugs directly to tumor cells. In contrast to traditional drug delivery modes, nanoparticles can be targeted to destroy tumor cells directly ...

8. Mitoxantrone (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

9. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

   Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

10. Q&A: Titrating medications pre-surgery for patients with pheochromocytoma and paraganglioma - Mayo Clinic

    A Mayo Clinic physician provides a basic framework for titrating medications before surgery for patients with pheochromocytoma and paraganglioma.